• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Ultragenyx Pharmaceutical Inc. (RARE)

    -NMS
    113.43 Up 5.33(4.93%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (59,802) (35,070) (16,334)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation4,284  1,857  313  
    Adjustments To Net Income8,718  3,558  1,193  
    Changes In Accounts Receivables -   -   -  
    Changes In Liabilities6,658  2,663  2,363  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(4,492)(4,208)(39)
    Total Cash Flow From Operating Activities (44,634) (31,200) (12,504)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(2,149)(407)(1,091)
    Investments(120,998)(47,352) -  
    Other Cash flows from Investing Activities(293)25  (100)
    Total Cash Flows From Investing Activities (123,440) (47,734) (1,191)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid(4,346) -   -  
    Sale Purchase of Stock189,317  171  89,140  
    Net Borrowings -   -  100  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 184,971   171   89,240  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 16,897   (78,763) 75,545  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.